跳至主要内容
临床试验/DRKS00020343
DRKS00020343已完成不适用

Study to measure biomarkers of collagen breakdown in COPD

Pneumolgisches Forschungsinstitut an der LungenClinic Grosshansdorf0 个研究点目标入组 133 人开始时间: 2019年12月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
133

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • - established diagnosis of COPD
  • - GOLD stage 1-3
  • - at least 10 py of smoking
  • - established diagnosis of asthma
  • - GINA 4 and 5 (at least medium-high dose of ICS/LABA combination)
  • - no chronic lung disease
  • - no inhaled medication
  • - for (ex-)-smoking controls: at least 10 py of smoking

排除标准

  • - respiratory tract infection or exacerbation within the last 4 weeks
  • - FEV1 less than 30%
  • - autoimmune disease that could affect collagen breakdown
  • - respiratory tract infection or exacerbation within the last 4 weeks
  • - FEV1 less than 30%
  • - autoimmune disease that could affect collagen breakdown
  • - respiratory tract infection within the last 4 weeks
  • - autoimmune disease that could affect collagen breakdown

研究者

发起方
Pneumolgisches Forschungsinstitut an der LungenClinic Grosshansdorf

相似试验